BERKELEY, Calif., May 5, 2009 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that Steven Engle, Chairman and Chief Executive Officer of XOMA, is scheduled to present at the Canaccord Adams Diabetes & Obesity Conference. The presentation will take place in New York City on Tuesday, May 12, at 9:00 a.m. Eastern Time.
